NYSEAMERICAN:XTNT Xtant Medical (XTNT) Stock Price, News & Analysis $0.54 +0.01 (+1.09%) (As of 11:03 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort Interest About Xtant Medical Stock (NYSEAMERICAN:XTNT) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Xtant Medical alerts:Sign Up Key Stats Today's Range$0.53▼$0.5450-Day Range N/A52-Week Range$0.51▼$1.45Volume15,226 shsAverage Volume99,680 shsMarket Capitalization$70.24 millionP/E RatioN/ADividend YieldN/APrice Target$2.25Consensus RatingBuy Company OverviewXtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.Read More… Could TSLA reach $500 a share? Free ebook says it’s possible. (Ad)Even though shares of Tesla are only up 3% this year, one man believes Tesla’s next bull run is just around the corner. In his professional opinion, the share price could reach $500 or more… Now, we understand that may seem far-fetched, but as you’ll see in his new ebook, it’s not as crazy as it may sound. In fact, he argues a Trump presidency could make it happen much faster than you might think. which is why we’re emailing you now… For the time being, he’s giving away his Tesla ebook for free. Inside explains how shares could reach $500 in the near future.To claim your copy, follow this link Xtant Medical Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks58th Percentile Overall ScoreXTNT MarketRank™: Xtant Medical scored higher than 58% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingXtant Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageXtant Medical has only been the subject of 1 research reports in the past 90 days.Read more about Xtant Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Xtant Medical is -27.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Xtant Medical is -27.22, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioXtant Medical has a P/B Ratio of 1.40. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.42% of the float of Xtant Medical has been sold short.Short Interest Ratio / Days to CoverXtant Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xtant Medical has recently decreased by 6.95%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldXtant Medical does not currently pay a dividend.Dividend GrowthXtant Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.42% of the float of Xtant Medical has been sold short.Short Interest Ratio / Days to CoverXtant Medical has a short interest ratio ("days to cover") of 2.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Xtant Medical has recently decreased by 6.95%, indicating that investor sentiment is improving significantly. News and Social Media2.0 / 5News SentimentN/A News SentimentXtant Medical has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Xtant Medical this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Xtant Medical insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.70% of the stock of Xtant Medical is held by insiders.Percentage Held by Institutions69.33% of the stock of Xtant Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Xtant Medical's insider trading history. Receive XTNT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xtant Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address XTNT Stock News HeadlinesXtant Medical Hldgs (AMEX:XTNT) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comXtant Medical Holdings: Xtant Medical Expands Product Portfolio with the Launch of the Cortera Posterior Fixation SystemSeptember 23, 2024 | finanznachrichten.deTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…November 5, 2024 | Timothy Sykes (Ad)Xtant Medical Holdings, Inc. (XTNT) Q2 2024 Earnings Call TranscriptAugust 10, 2024 | seekingalpha.comXtant Medical Holdings, Inc.: Xtant Medical Announces Closing of $5.0 Million Private PlacementAugust 9, 2024 | finanznachrichten.deXtant Medical Holdings, Inc.: Xtant Medical Reports Second Quarter 2024 Revenue Growth of 48%August 9, 2024 | finanznachrichten.deXTNT Stock Earnings: Xtant Medical Hldgs Misses EPS, Beats Revenue for Q2 2024August 8, 2024 | investorplace.comXtant Medical Holdings IncJuly 30, 2024 | money.usnews.comSee More Headlines XTNT Stock Analysis - Frequently Asked Questions How were Xtant Medical's earnings last quarter? Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT) issued its quarterly earnings data on Thursday, August, 8th. The medical device company reported ($0.03) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.01. The medical device company had revenue of $29.94 million for the quarter. Xtant Medical had a negative trailing twelve-month return on equity of 6.71% and a negative net margin of 3.00%. When did Xtant Medical's stock split? Xtant Medical shares reverse split before market open on Wednesday, February 14th 2018. The 1-12 reverse split was announced on Tuesday, February 13th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 13th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. Who are Xtant Medical's major shareholders? Xtant Medical's top institutional investors include Evernest Financial Advisors LLC (0.03%). Insiders that own company stock include Stavros G Vizirgianakis, Sean E Browne and Scott C Neils. View institutional ownership trends. How do I buy shares of Xtant Medical? Shares of XTNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Xtant Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Xtant Medical investors own include Meta Platforms (META), Aurinia Pharmaceuticals (AUPH), NVIDIA (NVDA), Alibaba Group (BABA), Block (SQ), Tesla (TSLA) and Broadcom (AVGO). Company Calendar Last Earnings8/08/2024Today11/05/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSEAMERICAN SectorMedical Industry Biological products, except diagnostic Sub-IndustryPharmaceutical Products Current SymbolNYSEAMERICAN:XTNT Previous SymbolAMEX:XTNT CUSIPN/A CIK1453593 Webxtantmedical.com Phone(406) 388-0480Fax406-388-1354Employees120Year FoundedN/APrice Target and Rating Average Stock Price Target$2.25 High Stock Price Target$3.00 Low Stock Price Target$1.50 Potential Upside/Downside+322.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$660,000.00 Net Margins-3.00% Pretax Margin-4.46% Return on Equity-6.71% Return on Assets-3.56% Debt Debt-to-Equity Ratio0.49 Current Ratio2.44 Quick Ratio1.01 Sales & Book Value Annual Sales$91.30 million Price / Sales0.76 Cash Flow$0.03 per share Price / Cash Flow18.54 Book Value$0.39 per share Price / Book1.37Miscellaneous Outstanding Shares130,310,000Free Float117,674,000Market Cap$69.48 million OptionableNot Optionable Beta0.39 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSEAMERICAN:XTNT) was last updated on 11/5/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredMissed Out On Nvidia?Artificial Intelligence is a tool with the potential to create massive distributions of wealth… In fact, it...Unstoppable Prosperity | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored626 winning trades out of 647…Imagine turning nearly every Friday into a payday. That's exactly what one reclusive multi-millionaire trad...Investing Daily | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xtant Medical Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Xtant Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.